检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:彭志平[1] 蒋明东[1] 王树斌[1] 尹晓玲[1] 张清华[1] 李少林[1]
机构地区:[1]重庆医科大学基础医学院放射医学教研室,重庆400016
出 处:《第四军医大学学报》2009年第5期401-404,共4页Journal of the Fourth Military Medical University
基 金:国家自然科学基金(30070230);重庆市科委基金(CSTC;2007BB5305)
摘 要:目的:探讨以c-erbB2 mRNA为靶点的反义寡脱氧核苷酸(ASODN)联合紫杉醇对乳腺癌SK-Br-3细胞的抑制作用.方法:实验分为7组:ASODN组,紫杉醇组,赫赛汀组,表阿霉素组,ASODN+紫杉醇组,赫赛汀+紫杉醇组,表阿霉素+紫杉醇组.分别处理乳腺癌SK-Br-3细胞72 h,MTT法测定细胞抑制率,中效原理判定药物联合应用的效果,WesternBlot检测细胞c-erbB2,Bcl-2蛋白表达水平.结果:各组中SK-Br-3细胞的抑制率均随药物浓度的增加而增大;紫杉醇的中效浓度紫杉醇组为0.14μmol/L;ASODN+紫杉醇组为0.07μmol/L,其合用指数(CI)<1,为协同作用.ASODN+紫杉醇组c-erbB2,Bcl-2蛋白表达明显低于紫杉醇组,两组相比较,差异具有统计学意义(P<0.05).结论:ASODN可明显增强紫杉醇对乳腺癌SK-Br-3细胞的抑制效应,可明显降低紫杉醇的用药量.AIM: To explore the inhibitory effect on human breast cancer SK-Br-3 cells treated with c-erhB2 antisense oli- godeoxynncleotide (ASODN) combined with taxol. METHODS : SK-Br-3 cells were treated with ASODN, taxol, hereeptin, Epiru- bicin, ASODN combined with taxol, herceptin combined with taxol, and Epirubicin combined with taxol for 72 h respectively. The inhibitory effect was detected by MTT assay. The drug's inter- aetional effect was determined by median-effect principle. The expression of e-erbB2 and Bel-2 was detected by western blot in SK-Br-3 cells. RESULTS: The inhibition ratio of each group increased while the increased concentration of drugs used. The median concentration of taxol was 0.14μmol/L in taxol group and 0.07μmol/L in ASODN combined taxol group respectively. The combination index(CI) of ASODN combined with taxol group was always less than 1, indicating that there was some synergistic effects between ASODN and taxol. The expression of c-erbB2 and Bcl-2 proteins was significantly lower in ASODN + taxol group than that in other groups and the difference was statistical significance ( P 〈 0.05 ). CONCLUSION : ASODN significantly enhances the inhibitory effect of taxol on human breast carcinoma SK-Br-3 cells and markedly lowers the taxol's dosage of administration.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222